COMMUNIQUÉS West-GlobeNewswire

MannKind to Report Third Quarter Financial Results and Host Conference Call on November 5, 2026
29/10/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced today that it will report third quarter 2026 financial results after market close on Thursday [...]
BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates
29/10/2026
- $353.2 million in total third quarter revenues, primarily comprised of $253.2 million of U.S. Attruby net product revenue (up approximately $31 million sequentially and $145 million year over year). Loss from [...]
Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlook
29/10/2026
Reports third-quarter revenue of $ 1.36 billion, representing 36.7% year-over-year growth Grows health plan membership 31.2% year-over-year to 301,200 members Issues fourth-quarter guidance and lowers full-year 2026 [...]
Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
29/10/2026
Solo Pace, Inc. specializes in temporary pacing solutions and systems designed for transcatheter heart valve procedures, including transcatheter aortic valve replacement procedures SOUTH JORDAN, Utah, Oct. 29, 2026 ( [...]
Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance
29/10/2026
Financial Highlights† Reported revenue of $416.2 million, up 8.4% Constant currency revenue* and constant currency revenue, organic* up 8% and up 9%, respectively GAAP operating margin of 14.1%, compared to 11.1% in [...]
CapsoVision to Release Third Quarter 2026 Financial Results on November 12, 2026
29/10/2026
SARATOGA, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced [...]
Pliant Therapeutics Announces Presentations at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer
29/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, [...]
Immuneering Reports Third Quarter 2026 Financial Results and Provides Business Updates
29/10/2026
- Phase 2 pancreatic cancer follow-up extended as patients on atebimetinib combinations live longer than projected - - Updated Phase 2 atebimetinib + mGnP pancreatic cancer data (N=55) expected in the first half of 2027 [...]
FOXO TECHNOLOGIES INC. ANNOUNCES AGREEMENTS TO ACQUIRE PREFERRED STOCK CARRYING MAJORITY VOTING POWER IN LUDWIG ENTERPRISES, INC.
29/10/2026
WEST PALM BEACH, FL, Oct. 29, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc . (OTC: FOXO) (“FOXO” or the “Company”) today announced that it has entered into Stock Purchase Agreements to acquire shares of preferred [...]
Stryker reports third quarter 2026 operating results
29/10/2026
Portage, Michigan, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2026: Third Quarter Results Reported net sales increased 7.7% to $6.5 billion Organic net sales [...]
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
29/10/2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
29/10/2026
Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basis Q1 GAAP diluted earnings per share up 23% to $2.92; non-GAAP diluted EPS up 14% to $2.91 Returned more than $1.0 billion to [...]
Supernus Announces Third Quarter 2026 Financial Results
29/10/2026
Record total revenues of $226.8 million in the third quarter 2026, an 18% increase compared to same period last year. Combined revenues of the Company's four growth products increased to $192.2 million in the third [...]
Strom Strategies Calls for a Possible "Black Box Warning" on Al Sayed’s Medicare for All Proposal
29/10/2026
Dr. Joel Strom raises questions about expanding the ACA, patient choice and the need for clear evidence on the plan’s effects. Frisco, TX, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Strom Strategies today called for a detailed [...]
Trethera Selected as a 2026–2027 National Cancer Institute Investor Showcase Company
29/10/2026
LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]
Retinal Robotics Pioneers Launch VisioSurgical Solutions (VSS) to Bring Compact Surgical Robots to Every Retina Surgeon
29/10/2026
LAUSANNE, Switzerland, Oct. 29, 2026 (GLOBE NEWSWIRE) -- VisioSurgical Solutions (VSS) , a Swiss medical robotics company founded by the team behind the first retinal surgery robot, today announced its launch and the [...]
Life with Jan Collaborates with Perrine SDA Church to Bring Renowned Physician Dr. Neil Nedley to South Florida
29/10/2026
Free November 6–7 Community Wellness Seminar Explores Depression, Anxiety, Brain Health, and Cancer Through a Wholistic Approach to Health and Wellbeing Miami, FLORIDA, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Life with Jan, [...]
Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange
29/10/2026
Funds that track these TASE benchmark indexes are expected to add Alpha Tau shares to their holdings TA-125 tracks the 125 largest and most prominent companies on the TASE JERUSALEM, Oct. 29, 2026 (GLOBE NEWSWIRE) -- [...]
aTyr Pharma Announces Publication of Results from the Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis in The Lancet Respiratory Medicine
29/10/2026
Peer-reviewed publication reinforces efzofitimod’s differentiated profile and potential to advance pulmonary sarcoidosis care. SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum